Michael J. Mauro

2 ta ish

Myeloproliferative Neoplasms Program, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

1. Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database

   Elisabetta Abruzzese, Anna Turkina, Jane F. Apperley +21

   MaqolaChronic Myeloid Leukemia TreatmentsBlood20190 iqtibos

   ABIABI:AkademIndex/openalex/2019.article.000226

2. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial

   Jane F. Apperley, Jörge E. Cortes, Elias Jabbour +21

   MaqolaChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

   ABIABI:AkademIndex/openalex/2023.article.010140